B. An eligible facility or manufacturer operating within an eligible facility may do both of the following:
1. Provide an individualized investigational drug, biological product or device to an eligible patient without receiving compensation.
2. Require an eligible patient to pay the costs of, or the costs associated with, the manufacture of the individualized investigational drug, biological product or device.